Chronic kidney disease and nonalcoholic fatty liver disease proven by transient elastography

Kidney and Blood Pressure Research

Volumn 37, Issue 4-5, 2013, Pages 305-310

  Mikolasevic, Ivana ^a   Racki, Sanjin ^a   Bubic, Ivan ^a   Jelic, Ita ^a   Stimac, Davor ^a   Orlic, Lidija ^a  

^a KBC RIJEKA   (Croatia)

Author keywords

Chronic kidney disease; Fibroscan ; Non alcoholic fatty liver disease

Indexed keywords

C REACTIVE PROTEIN; CREATININE; EPIDERMAL GROWTH FACTOR RECEPTOR; IRON; ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UREA;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; ELASTOGRAPHY; FEMALE; HEPATOBILIARY PARAMETERS; HUMAN; IRON BLOOD LEVEL; KIDNEY FUNCTION; LIVER FIBROSIS; LIVER STIFFNESS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; ELASTOGRAPH; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; MIDDLE AGED; SCREENING; TRANSIENT ELASTOGRAPHY; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL;

AGED; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC;

EID: 84890401791     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000350158     Document Type: Article

References (16)

1. Dowman JK, Tomlinson JW, Newsome PN: Systematic review: The diagnosis and staging of non-Alcoholic fatty liver disease and non-Alcoholic steatohepatitis. Aliment Pharmacol Ther 2011;33:525-540
2. Targher G, Arcaro G: Non-Alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007;191:235-240
3. Farrel GC, Larter CZ: Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology 2006;43:S99-S112
4. Starley BQ, Calcagno CJ, Harrison SA: Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection. Hepatology 2010;51:1820-1832
5. Kim CH, Younossi ZM: Non alcoholic fatty liver disease: A manifestation of metabolic syndrome. Cleve Clin J Med 2008;75:721-728
6. Targher G, Bertolini L, Rodella S, Lippi G, Zoppini G, Chonchol M: Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. Clin J Am Soc Nephrol 2010;5:2166-2171
7. Hamad AA, Khalil AA, Connolly V, Ahmed MH: Relationship between non-Alcoholic fatty liver disease and kidney function: A communication between two organs that needs further exploration. Arab J Gastroenterol 2012;13:161-165
8. YYasui K, Sumida Y, Mori Y, Mitsuyoshi H, Minami M, Itoh Y, Kanemasa K, Matsubara H, Okanoue T, Yoshikawa T: Nonalcoholic steatohepatitis and increased risk of chronic kidney disease. Metabolism 2011;60:735-739
9. Martinez SM, Crespo G, Navasa M, Forns X: Noninvasive assessment of liver fibrosis. Hepatology 2011;53:325-335
10. Sasso M, Beaugrand M, de Ledinghen V, Douvin C, Marcellin P, Poupon R, Sandrin L, Miette V: Controlled attenuation parameter (CAP): A novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: Preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 2010;36:1825-1835
11. Targher G, Kendrick J, Smits G, Chonchol M: Relationship between serum gamma-glutamyltransferase and chronic kidney disease in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001-2006. Nutr Metab Cardiovasc Dis 2010;20:583-590
12. Targher G, Bosworth C, Kendrick J, Smits G, Lippi G, Chonchol M: Relationship of serum bilirubin concentrations to kidney function and albuminuria in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001-2006. Clin Chem Lab Med 2009;47:1055-1062
13. Yilmaz Y, Alahdab YO, Yonal O, Kurt R, Kedrah AE, Celikel CA, Ozdogan O, Duman D, Imeryuz N, Avsar E, Kalayci C: Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: Association with liver fibrosis. Metabolism 2010;59:1327-1330
14. Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V, Whelton PK, He J: Insulin resistence and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 2003;14:469-477
15. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J: The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004;140:167-174
16. Milic S, Stimac D: Nonalcoholic fatty liver disease/steatohepatitis: Epidemiology, pathogenesis, clinical presentation and treatment. Dig Dis 2012;30:158-162